| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.00026 | 1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0002 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 9.7e-05 | 1 |